Infectious Diseases

Supporting Infectious Diseases Research

Infectious diseases continue to be a significant global health challenge, affecting millions of people each year.

According to the World Health Organization, bacterial infections alone caused approximately 7.7 million deaths worldwide in 2019, making them one of the leading causes of death globally​¹. The economic burden is also substantial, with pharmaceutical companies investing heavily in research and development to combat these diseases. In 2020, it was estimated that global R&D spending on infectious diseases, including both public and private sectors, exceeded $214 billion. This substantial investment highlights the critical need for innovative research and effective treatment strategies to manage and reduce the impact of infectious diseases.

Sampled offers extensive support for researchers working on infectious diseases, providing a range of services that enhance reproducibility and precision. By offering cryogenic storage, Sampled ensures that valuable biological samples are preserved under optimal conditions, reducing the risk of degradation. Our next-generation sequencing (NGS) and microarray services enable high-throughput analysis of genetic material, facilitating the identification of pathogens and understanding of disease mechanisms. Additionally, Sampled’s expertise in biobanking and regulatory compliance ensures that samples are handled and stored according to the highest standards, which is crucial for maintaining data integrity throughout the research process. These comprehensive services support researchers in developing effective treatments and interventions for infectious diseases, ultimately contributing to improved global health outcomes.